Challenges and solutions for therapeutic TCR-based agents.

Malviya M, Aretz ZEH, Molvi Z, Lee J, Pierre S, Wallisch P, Dao T, Scheinberg DA.

Open source

DOI
10.1111/imr.13233
Published
2023-07-16
Container
Immunol Rev
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/imr.13233,
  title = {Challenges and solutions for therapeutic TCR-based agents.},
  author = {Malviya M and  Aretz ZEH and  Molvi Z and  Lee J and  Pierre S and  Wallisch P and  Dao T and  Scheinberg DA.},
  year = {2023},
  journal = {Immunol Rev},
  doi = {10.1111/imr.13233},
  url = {https://doi.org/10.1111/imr.13233}
}

RIS

TY  - JOUR
TI  - Challenges and solutions for therapeutic TCR-based agents.
AU  - Malviya M
AU  -  Aretz ZEH
AU  -  Molvi Z
AU  -  Lee J
AU  -  Pierre S
AU  -  Wallisch P
AU  -  Dao T
AU  -  Scheinberg DA.
PY  - 2023
JO  - Immunol Rev
DO  - 10.1111/imr.13233
UR  - https://doi.org/10.1111/imr.13233
ER  - 

APA

M, M., ZEH, A., Z, M., J, L., S, P., P, W., T, D., & DA., S. (2023). Challenges and solutions for therapeutic TCR-based agents.. Immunol Rev. https://doi.org/10.1111/imr.13233

Source records